Surgery Websites
Bariatric Surgery »  Meet the Team »  Research Faculty »  Anne Schafer, M.D.
Anne Schafer, M.D.

Anne Schafer, M.D.

  • Assistant Professor Department of Medicine - VAMC

Contact Information

4150 Clement Street
San Francisco CA 94121
Phone 415-221-4810x4895
Anne.Schafer@ucsf.edu
Open Popup

UCSF School of Medicine, M.D., 2004 

  • Internal Medicine, UCSF
  • American Board of Internal Medicine - General
  • American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism Subspecialty
  • UCSF Department of Medicine
  • UCSF Bariatric Surgery Program
  • SF VAMC
  • Dr. Schafer is Assistant Professor of Medicine and of Epidemiology & Biostatistics at UCSF and a practicing endocrinologist at the San Francisco VA Medical Center. She is board-certified in by the American Board of Internal Medicine in Internal Medicine and by the American Board of Internal Medicine in Endocrinology, Diabetes and Metabolism Subspecialty.
Dr. Schafer is Professor of Medicine and of Epidemiology & Biostatistics at UCSF and Chief of Endocrinology and Metabolism at the San Francisco VA Health Care System. She is board-certified by the American Board of Internal Medicine in the subspecialty of Endocrinology, Diabetes and Metabolism. Her research focus is osteoporosis and bone metabolism. One of her research emphases is osteoporosis treatment and the assessment of response to osteoporosis therapy. She also studies the relationships between bone, fat, and glucose metabolism, including the effects of obesity and diabetes on bone, and the skeletal regulation of energy metabolism. This research program includes investigations of the effects of bariatric surgery (weight loss surgery) on calcium metabolism and skeletal health. Dr. Schafer's research has been funded by the National Institutes of Health, the US Department of Veterans Affairs, and the American Society for Bone and Mineral Research.

Her research focus is on osteoporosis and metabolic bone disease. One of her specific research emphases is osteoporosis treatment and the assessment of response to osteoporosis therapy. Pharmacologic treatment for osteoporosis may involve the use of an antiresorptive agent (one that decreases bone resorption) or an anabolic agent (one that stimulates bone formation). Dr. Schafer and colleagues conducted a randomized, placebo-controlled trial testing two innovative combinations of concurrent and sequential anabolic and anti-resorptive therapy in postmenopausal women with low bone mass. Findings from the trial may help to expand treatment options for osteoporosis. Additionally, Dr. Schafer is actively engaged in research involving the relationship between bone and fat. Bone-fat interplay—including the effects of fat on bone metabolism and the skeletal regulation of energy metabolism—is an area of increasing investigation. Currently, she is studying the effects of bariatric surgery (surgical weight loss) on calcium metabolism and skeletal health. Her research is funded by the U.S. Department of Veterans Affairs, the National Institutes of Health (National Institute on Diabetes and Digestive and Kidney Diseases), and the American Society for Bone and Mineral Research.

Data provided by UCSF Profiles, powered by CTSI
  • Skeletal Health in Type 1 Diabetes and the Role of Diabetic Kidney Disease
    Sponsor:
    Sponsor ID:
    Funding Period:
    Sep 2020
    -
    Jul 2024
    Principal Investigator
  • Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jun 2020
    -
    Jun 2024
    Principal Investigator (MPI)
  • FSH - an Aging Hormone?
    Sponsor:
    Sponsor ID:
    Funding Period:
    Feb 2019
    -
    Jan 2024
    Subaward PI
  • Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton
    Sponsor:
    Sponsor ID:
    Funding Period:
    Mar 2016
    -
    Feb 2021
    Principal Investigator
  • Prebiotic Intervention to Improve Calcium Absorption After Gastric Bypass Surgery
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jul 2017
    -
    Mar 2019
    Principal Investigator
  • Effects of Gastric Bypass Surgery on Calcium Metabolism and the Skeleton
    Sponsor:
    Sponsor ID:
    Funding Period:
    Apr 2011
    -
    Jun 2016
    Principal Investigator
Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 68
Data provided by UCSF Profiles, powered by CTSI
  1. Kim TY, Schwartz AV, Li X, Xu K, Kazakia GJ, Grunfeld C, Nissenson RA, Shoback DM, Schafer AL. Bone marrow adipose tissue composition and glycemic improvements after gastric bypass surgery. Bone Rep. 2022 Dec; 17:101596. View in PubMed
  2. Babey ME, Ewing SK, Strotmeyer ES, Napoli N, Schafer AL, Vittinghoff E, Gundberg CM, Schwartz AV. No Evidence of Association Between Undercarboxylated Osteocalcin and Incident Type 2 Diabetes. J Bone Miner Res. 2022 05; 37(5):876-884. View in PubMed
  3. Sadoughi S, Pasco C, Joseph GB, Wu PH, Schafer AL, Kazakia GJ. Cortical Bone Loss Following Gastric Bypass Surgery Is Not Primarily Endocortical. J Bone Miner Res. 2022 04; 37(4):753-763. View in PubMed
  4. Woods GN, Ewing SK, Schafer AL, Gudnason V, Sigurdsson S, Lang T, Hue TF, Kado DM, Vittinghoff E, Rosen C, Li X, Schwartz AV. Saturated and Unsaturated Bone Marrow Lipids Have Distinct Effects on Bone Density and Fracture Risk in Older Adults. J Bone Miner Res. 2022 04; 37(4):700-710. View in PubMed
  5. Wu KC, Cao S, Weaver CM, King NJ, Patel S, Kingman H, Sellmeyer DE, McCauley K, Li D, Lynch SV, Kim TY, Black DM, Shafer MM, Özçam M, Lin DL, Rogers SJ, Stewart L, Carter JT, Posselt AM, Schafer AL. Prebiotic to Improve Calcium Absorption in Postmenopausal Women After Gastric Bypass: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2022 03 24; 107(4):1053-1064. View in PubMed
  6. View All Publications

 

Site Directory
    X